Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3,082.16 | 16.36 |
| PEG Ratio (TTM) | 24.18 | -0.21 |
| P/S Ratio (TTM) | 3.63 | 2.63 |
| P/B Ratio (TTM) | 0.77 | 1.44 |
| P/FCF Ratio (TTM) | -489.75 | 6.43 |
| Price to 5YR AVG Earnings Ratio | 66.98 | 15.13 |
| Price to 5YR AVG FCF Ratio | 90.95 | 9.39 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.00% | 0.95% |
| ROE (TTM) | -0.03% | 9.40% |
| Net Profit Margin (TTM) | -0.11% | 16.47% |
| ROIC 5YR AVG | 2.27% | 17.21% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 258.66% | 28.67% | -6.44% |
| Revenue | 3.39% | 18.98% | 7.25% |
| Net Income | 228.26% | 44.01% | 0.83% |
| Cash Flow | -25.21% | 536.41% | 303.93% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 19.14 | 12.54 |
| Quick Ratio (TTM) | 19.14 | 12.76 |
| D/E Ratio (TTM) | 0.30 | 1.04 |
| Interest Coverage (TTM) | -0.03 | 0.73 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.52 | 0.43 |
| LTL to 5YR AVG FCF | 7.03 | 5.97 |
| Shares Outstanding Growth 5YR AVG | 40.15% | 56.58% |